Introduction {#S0001}
============

The main purpose of aortic valve replacement (AVR) is to reduce the pressure or volume load on the left ventricle and thus avoid the progression of left ventricular remodeling. During the last 5 decades, valve prosthetics have evolved, and their usage expanded greatly. However, small aortic root size in comparison to body mass index (BMI) continues to pose a challenge for cardiac surgeons. In recent decades, new high-performance prostheses have been invented for use with small aortic annuli, and these have contributed to the avoidance of patient prosthesis mismatch (PPM) without the need for aortic annular enlargement.

In this study, we report the trends of aortic valvular replacement and root enlargement operations performed in our clinic between 1999 and 2008.

Material and methods {#S0002}
====================

Between 1999 and 2009, we performed open heart surgery on 16 764 patients. Of these operations, 4687 involved valve surgery. Aortic valve operations were less common than mitral valve repair. During this period, we conducted 1397 aortic valve operations, including 60 aortic valve reconstructions.

The data of 1337 consecutive patients who underwent AVR with or without concomitant posterior aortic annulus enlargement between January 1999 and January 2009 were included in the study. Patients with aortic dissections and patients who underwent Bentall and Ross procedures were excluded from the analysis. Patients were grouped according to the employed aortic valve size. The data were collected and analyzed retrospectively.

All patients were operated on using median sternotomy and were placed on cardiopulmonary bypass with high aortic and dual-stage right atrial cannulation. A membrane oxygenator and arterial filter were routinely used. Antegrade and retrograde warm and cold blood cardioplegia was employed. Prostheses were implanted into the intra-annular position with interrupted pledgeted sutures. Patients who required annular enlargement underwent either the Nicks \[[@CIT0001]\] or the Manouguian procedure \[[@CIT0002]\].

The data were analyzed using SPSS (Statistical Package for Social Sciences) version 15, 2006 Statistical Software (USA). Continuous variables were summarized as mean and standard deviation, while categorical variables were described as the number of subjects and percentage. In the study, we classified numeric variables, and we used a χ^2^ test for univariate analysis. The Mann-Whitney test and 1-way ANOVA (Kruskal-Wallis and Dunn\'s multiple comparison tests) were used as appropriate. *P* values \< 0.05 were considered statistically significant, and the confidence interval was 95%.

Results {#S0003}
=======

The mean age of the study population was 54.37 ± 17.35 (range: 10-84). Men constituted 65.8% of the study group (*n* = 881). Seven hundred and three (*n* = 703) (52.5%) patients were diagnosed with isolated aortic stenosis, 199 (14.8%) with both aortic stenosis and regurgitation. The Nicks procedure was performed in 25 patients (1.9%). Study population properties are summarized in [Table I](#T0001){ref-type="table"} and [II](#T0002){ref-type="table"}.

###### 

Study parameters

  Parameter                                                 *n*    \%
  --------------------------- ----------------------------- ------ ------
  Age (year)                  54.37 ± 17.35 (range 10-84)          
  Sex (f)                                                   456    34.1
  Aortic stenosis                                           703    52.5
  Aortic regurgitation                                      435    32.5
  Regurgitation + stenosis                                  199    14.8
  Additional disease          Mitral regurgitation          225    34.8
  Mitral stenosis             90                            13.9   
  Ascending aortic aneurysm   170                           26.3   
  Other                       160                           24.8   
  Aortic valve size           19                            106    7.9
  21                          526                           39.3   
  23                          468                           35.0   
  25                          223                           16.7   
  27                          12                            0.9    
  29                          2                             0.1    
  Aortic root enlargement     Nicks                         25     1.9
  Manouguian                  6                             0.4    
  Additional procedure        Mitral valve replacement      312    23.3
  Other                       333                           24.9   
  Mitral valve size           25                            17     5.6
  27                          73                            23.3   
  29                          121                           38.9   
  31                          80                            25.6   
  33                          21                            6.7    
  Redo                                                      37     2.8
  Hospital mortality                                        33     2.5

###### 

Patients' sex distribution by year

  Sex      Year        *p*                                                                                                              
  -------- ----------- ----------- ----------- ----------- ----------- ------------ ------------ ------------ ------------ ------------ -------
  Female   29 (38.7)   28 (34.6)   29 (30.5)   39 (35.5)   48 (37.2)   49 (29.9)    48 (31.5)    54 (32.7)    66 (38.2)    66 (34.0)    0.839
  Male     46 (61.3)   53 (65.4)   66 (69.5)   71 (64.5)   81 (62.8)   115 (70.1)   103 (68.2)   111 (67.3)   107 (61.8)   128 (66.0)   

No relationship was observed between age and preferred valve size (*p* \> 0.05). However, sex did affect the valve size: female patients were implanted mostly with 19 or 21 sized valves, while male patients were more often implanted with size 23 or 25 (*p* \< 0.01).

We observed an absolute increase in the number of aortic valve replacement procedures during the studied period (75 cases in 1999 and 194 cases in 2008). The number of aortic root enlargement procedures decreased over the years (*p* = 0.0002); particularly, the decline of the Nicks procedure was statistically significant (5 cases in 1999 and 2 cases in 2008) (*p* \< 0.05). It was noteworthy that despite the decrease in the number of aortic root enlargement operations, the preferred valve size increased. In 2008, the most frequently used valve size was 23, whereas size 21 was preferred in 1999 (*p* \< 0.05). The primary pathophysiology leading to aortic valve replacement, aortic stenosis, did not change over the years (*p* \> 0.05). Although the use of combined surgery increased over the years, there was no statistically significant increase in mortality rates (*p* \> 0.05).

Discussion {#S0004}
==========

A population of patients undergoing AVR with or without root enlargement in our clinic from 1999 to 2009 was defined. An absolute increase was observed in the number of aortic valve replacement procedures during the studied period. However, the primary pathology leading to surgery, i.e. aortic stenosis, did not change over the years ([Table IIIA](#T0003){ref-type="table"}, [B](#T0004){ref-type="table"}). Parallel to our results, Northrup *et al*. described a certain increase in aortic valve operations \[[@CIT0003]\]. The profile of aortic valve disease with dominant aortic stenosis depicted in the present study (*n* = 703; 52.5%) is similar to other surgical series \[[@CIT0003]--[@CIT0006]\]. Consistent with the present data, there appears to be a trend towards more surgical complexity in aortic valve operations. However, in contradiction to our results, there are papers advocating more combined CAB in aortic valve operations \[[@CIT0003], [@CIT0007]--[@CIT0009]\]. In this study, we have observed more combined mitral valve operations in comparison to other procedures (312 and 333, respectively; *p* \> 0.05) ([Table IVA](#T0005){ref-type="table"}, [B](#T0006){ref-type="table"}).

###### 

Aortic valve pathology by year

                             Year        *p*                                                                                                          
  -------------------------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ------------ -------
  Aortic stenosis            39 (52.0)   45 (55.6)   54 (56.8)   60 (54.5)   69 (53.5)   89 (54.3)   81 (53.6)   72 (43.6)   86 (49.7)   108 (55.7)   0.527
  Aortic regurgitation       25 (33.3)   23 (28.4)   30 (31.6)   35 (31.8)   39 (30.2)   50 (30.5)   40 (26.5)   69 (41.8)   64 (37.0)   60 (30.9)    0.206
  Stenosis + regurgitation   11 (14.7)   13 (16.0)   11 (11.6)   15 (13.6)   21 (16.3)   25 (15.2)   30 (19.9)   24 (14.5)   23 (13.3)   26 (13.4)    0.842

###### 

Preoperative aortic valve properties and aortic prosthesis size

  Properties                 Aortic valve size   *p*                                                          
  -------------------------- ------------------- ------------ ------------ ------------ ---------- ---------- -------
  Aortic stenosis            40 (5.3)            199 (26.3)   379 (50.0)   97 (13.2)    20 (2.6)   20 (2.6)   0.603
  Aortic regurgitation       0 (0.0)             234 (37.5)   259 (41.7)   104 (16.7)   26 (4.2)   0 (0.0)    0.722
  Stenosis + regurgitation   0 (0.0)             10 (25.0)    31 (75.0)    0 (0.0)      0 (0.0)    0 (0.0)    0.855

###### 

Relationship between additional operation and the used aortic valve size

  Properties   Aortic valve size   *p*                                                                   
  ------------ ------------------- ------------ ------------ ----------- ---------- --------- ---------- -------
  AVR + MVR    AVR + MVR           22 (7.1)     156 (50.0)   90 (28.6)   22 (7.1)   0 (0.0)   22 (7.1)   0.398
  Other        0 (0.0)             102 (30.8)   154 (46.2)   77 (23.1)   0 (0.0)    0 (0.0)              

AVR -- aortic valve replacement, MVR -- mitral valve replacement

###### 

Redo cases by year

         Year      *P*                                                                                       
  ------ --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- -------
  Redo   2 (2.7)   2 (2.5)   3 (3.2)   4 (3.6)   3 (2.3)   5 (3.0)   6 (4.0)   4 (2.4)   2 (1.2)   6 (3.1)   0.957

The procedure of anterior or posterior annular enlargement may be performed in a patient with a small aortic root to enable the implantation of a larger valve. The posterior approach is the one most commonly used in adults, and it can increase the annular diameter by 2 to 4 mm. In the Nicks technique of root enlargement, the aortotomy is extended downward through the non-coronary cusp and the aortic annulus to the anterior mitral leaflet \[[@CIT0001]\]. In the Manouguian procedure, the aortotomy incision extends downward through the commissure between the left and non-coronary cusps into the interleaflet triangle and the anterior leaflet of the mitral valve \[[@CIT0002]\]. The anterior approach is generally used in the pediatric population. Described by Konno *et al*. in 1975, this technique, also known as aortoventriculoplasty, is used when annular enlargement of more than 4 mm is required \[[@CIT0010]\]. Instead of a transverse incision, a longitudinal incision is made in the anterior aorta and extended to the right coronary sinus of Valsalva and then through the anterior wall of the right ventricle to open the right ventricular outflow tract. The ventricular septum is incised, allowing the aortic annulus and left ventricular outflow tract to expand significantly.

Attention needs to be drawn to the fact that the technological development of mechanical valve characteristics has enabled the avoidance of root enlargement and postoperative left ventricular outflow gradient. Over the past 25 years, changes have been made in the design and configuration of bileaflet prostheses. The sewing ring of the SJM valve has changed (SJM HP) to enable larger valve implantation in any given annulus tissue, as has the ATS Medical prosthesis with its AP design. The sewing ring of the Sulzer CarboMedics valve has been modified so that the valve is implanted in a supravalvular position (top hat model). The On-X valve incorporates advanced pyrolytic carbon technology, using a purer, more flexible coating to allow flanging of the inflow portion of the valve housing, mimicking the normal flow pattern \[[@CIT0011]\]. New mechanical valves have good hemodynamic properties and lower root enlargement rates when compared to the older types.

However, the debate on patient-prosthesis mismatch (PPM) continues. We observed a statistically significant decrease in the number of aortic root enlargement procedures (*p* \< 0.05, [Table VA](#T0007){ref-type="table"}). Particularly, the number of Nicks procedures declined over the years (*p* \< 0.010, [Table VB](#T0008){ref-type="table"}). Blais *et al*., Adams *et al*., and De Paulis *et al*. reported no difference in overall valve-related mortality between patients who had severe PPM, moderate PPM, or significant PPM \[[@CIT0012]--[@CIT0014]\]. On the other hand, Zapolanski *et al*. and Jamieson *et al*. reported that PPM was related to early mortality after aortic valve replacement \[[@CIT0015], [@CIT0016]\]. Conversely to the decrease in aortic root enlargement operations, this study observed a trend to choose larger aortic valves: size 21 was the one most frequently used in 1999, whereas size 23 was preferred in 2008 (*p* \< 0.05, [Table VI](#T0009){ref-type="table"}).

###### 

Aortic root enlargement procedures by year

                            Year   *p*                                                                                                 
  ------------------------- ------ --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ----------
  Aortic root enlargement   with   5 (7.1)   5 (6.5)   3 (3.2)   4 (3.7)   2 (1.5)   4 (2.5)   2 (1.3)   2 (1.2)   2 (1.1)   2 (1.0)   0.000295
  without                   70     76        92        106       127       160       149       163       171       192                 

###### 

Nicks and Manouguian procedures by year

               Year      *p*                                                                                       
  ------------ --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- -------
  Manouguian   0 (0.0)   1 (1.2)   0 (0.0)   0 (0.0)   0 (0.0)   2 (1.2)   1 (0.7)   1 (0.6)   0 (0.0)   1 (0.5)   0.721
  Nicks        5 (6.7)   4 (4.9)   3 (3.2)   4 (3.6)   2 (1.6)   2 (1.2)   1 (0.7)   1 (0.6)   2 (1.2)   1 (0.5)   0.010

###### 

Aortic valve size by year

  Aortic valve size   Year        *p*                                                                                                         
  ------------------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- -------
  19                  8 (10.7)    9 (11.1)    10 (10.5)   11 (10.0)   12 (9.3)    12 (7.3)    13 (8.6)    12 (7.3)    9 (5.2)     10 (5.2)    0.004
  21                  32 (42.7)   33 (40.7)   39 (41.1)   47 (42.7)   55 (42.6)   72 (43.9)   62 (41.1)   55 (33.3)   67 (38.7)   64 (33.0)   
  23                  22 (29.3)   26 (32.1)   28 (29.5)   36 (32.7)   42 (32.6)   51 (31.1)   45 (29.8)   59 (35.8)   70 (40.5)   89 (45.9)   
  25                  13 (17.3)   13 (16.0)   18 (18.9)   16 (14.5)   20 (15.5)   29 (17.7)   31 (20.5)   39 (23.6)   20 (11.6)   24 (12.4)   
  27                  0 (0.0)     0 (0.0)     0 (0.0)     0 (0.0)     0 (0.0)     0 (0.0)     0 (0.0)     0 (0.0)     6 (3.5)     6 (3.1)     
  29                  0 (0.0)     0 (0.0)     0 (0.0)     0 (0.0)     0 (0.0)     0 (0.0)     0 (0.0)     0 (0.0)     1 (0.6)     1 (0.5)     

As myocardial protection and prosthetic valve technology improved, hospital mortality declined between the 1980s and 1990s; stable hospital mortality was reported during the 1990s \[[@CIT0006], [@CIT0007], [@CIT0009], [@CIT0017]\]. This study has observed stable hospital mortality rates during the studied period ([Table VIIA](#T0010){ref-type="table"}--[C](#T0012){ref-type="table"}, *p* \> 0.05).

###### 

Mortality by year

              Year      *p*                                                                                       
  ----------- --------- --------- --------- --------- --------- --------- --------- --------- --------- --------- -------
  Mortality   2 (2.7)   1 (1.2)   2 (2.1)   3 (2.7)   2 (1.6)   2 (1.2)   4 (2.6)   6 (3.6)   5 (2.9)   6 (3.1)   0.940

###### 

Relationship between hospital mortality and aortic prosthetic valve size

              Aortic valve size   *p*                                                   
  ----------- ------------------- ---------- ----------- ---------- --------- --------- -------
  Mortality   7 (20.0)            7 (20.0)   12 (40.0)   7 (20.0)   0 (0.0)   0 (0.0)   0.423

###### 

Relationship between additional procedures and mortality

              Additional procedure   *p*                    
  ----------- ---------------------- ---------- ----------- -------
  Mortality   8 (0.5)                11 (0.8)   14 (1.04)   0.808

AVR -- aortic valve replacement, MVR -- mitral valve replacement

Other authors have demonstrated surgical complexity to be a risk factor for hospital mortality \[[@CIT0003], [@CIT0008], [@CIT0009], [@CIT0018], [@CIT0019]\]. In the present study, we have also observed an increase in early mortality after combined surgery ([Table VIIA](#T0010){ref-type="table"}--[C](#T0012){ref-type="table"}), but without statistical significance (*p* \> 0.05). The overall short-term outcomes after AVR with or without combined surgery were excellent. The low risk of AVR associated with combined surgery supports the consideration for earlier surgical referral and intervention in patients with a high likelihood of aortic stenosis progression. It is noteworthy that surgical complexity by itself creates only a modest risk and, therefore, should not be a contraindication to aortic valve surgery in the future.

Conclusions {#S0005}
===========

This study showed that avoiding the procedure of aortic root enlargement and implanting larger valves with high-performance prostheses is safe.
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